Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
I-MAK Makes Submission to the Indian Parliamentary Standing Committee on Improving the Patent System
GlaxoSmithKline Withdraws Patent Applications For Antiretrovirals
GSK withdraws its application for Abacavir in India
GSK drops claims on two Aids medicines
What’s happening: An update on HIV drugs in India
Time to re-write or clarify the pre-grant opposition rules?
Pre-95 drugs are not patentable in India – or are they?
News on I-MAK Study on 2nd Line HIV drugs
What’s Happening: An Update on HIV Drug Patents
En Garde!